.
MergerLinks Header Logo

New Deal

New Deal

Cover Image George Nakayama
George NakayamaDAIICHI SANKYO COMPANY LIMITED

George Nakayama

Chairman and CEO at DAIICHI SANKYO COMPANY LIMITED

Manager

Deal Bio

Total Deals1
Valued Deals1
Total Value£5,258M
Avg. Deal Size£5,258M
Japan
Pharmaceuticals
PrivateAcquisitionJoint Venture
Daiichi Sankyo (trastuzumab Deruxtecan)

target

Daiichi Sankyo (trastuzumab Deruxtecan)

Astrazeneca

bidder

Astrazeneca

£5,258m

11 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US